Short And Long-Term Cost-Effectiveness Of Switching Therapy From Biphasic Human Insulin 30 To Biphasic Insulin Aspart 30 In People With Type-2 Diabetes

✍ Scribed by Home, P.D.; Soewondo, P.; Hussein, Z.; Shafie, A.A.; AlRaddady, K.; Baadbad, R.; Hammerby, E.; Nikolajsen, A.; Andersen, M.F.B.; Henriksen, O.

• Book ID: 122318551
• Publisher: John Wiley and Sons
• Year: 2013
• Tongue: English
• Weight: 74 KB
• Volume: 16
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2013.03.819